Intrinsic Value of S&P & Nasdaq Contact Us

HUTCHMED (China) Limited HCM NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • HK • USD

SharesGrow Score
81/100
4/7 Pass
SharesGrow Intrinsic Value
$42.95
+182.4%
Analyst Price Target
$17.50
+15.1%

Stock Statistics — HCM

HUTCHMED (China) Limited (HCM) has a market capitalization of $2.65B and trades at $15.21. The 52-week range is 11.505-19.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 5.7, Earnings Per Share (EPS) of $2.65, annual revenue of $549.96M.

The stock has a beta of 0.45, operates in the Healthcare sector.

Trading Data
Current Price$15.21
52-Week Range11.505-19.5
Volume27.55K
Avg Volume (30D)30.93K
Market Cap$2.65B
Beta (1Y)0.45
Company
IPO Date2016-03-16
Employees1,811
CEOChig Fung Cheng
CountryHK
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS44842L1035
CUSIP44842L103
Income (Latest Year)
Revenue$549.96M
Gross Profit$212.72M
EBITDA$-41.38M
Operating Income$-54.73M
Net Income$458.12M
EPS$2.65
EPS Diluted$2.60
Shares Outstanding$171.66M
Balance Sheet (Latest Year)
Total Assets$1.75B
Current Assets$1.57B
Cash & ST Investments$1.37B
Total Liabilities$501.84M
Total Debt$97.89M
Net Debt$26.56M
Total Equity$1.25B
Debt / Equity0.08
Valuation Ratios
P/E Ratio5.7
P/S Ratio4.83
P/B Ratio2.12
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message